A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
Clinical trial NCT06359899 · COMPLETED
Trial details
- NCT number
- NCT06359899
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2025-01-06
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.